Anticoagulant linked with lower risk of death following heart attack compared to heparin

Patients who experienced a certain type of heart attack who received the anticoagulant fondaparinux had a lower risk of major bleeding events and death both in the hospital and after six months compared to patients who received low-molecular-weight heparin (LMWH), although both groups had similar rates of subsequent heart attack or stroke, according to a study in the Feb. 17 issue of JAMA. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *